Showing 6,981 - 7,000 results of 7,608 for search '"Oncology"', query time: 0.07s Refine Results
  1. 6981

    Blastic plasmacytoid dendritic cell neoplasm: a Swiss case series of a very rare disease and a structured review of the literature by Ramona Meier-Lienhard, Cosima Suter, Thomas Pabst, Felicitas Hitz, Jakob R. Passweg, Olivier Spertini, Nathan Cantoni, Daniel Betticher, Lucas Simeon, Michael Medinger, Stefanie Hayoz, Adrian Schmidt

    Published 2025-01-01
    “…METHODS: We collected data from BPDCN patients from leading Swiss haemato-oncology centres from 2005 to 2022. Furthermore, we reviewed and analysed the published literature (cohorts and case reports in peer-reviewed journals) from 1997 to 2020 (structured review of the literature). …”
    Get full text
    Article
  2. 6982
  3. 6983

    Estimating the Cost-Effectiveness of Tumor Treating Fields (TTFields) Therapy with an Immune Checkpoint Inhibitor or Docetaxel in Metastatic Non-Small Cell Lung Cancer by Furnback W, Wu E, Koh CYC, Nino de Rivera Guzman JF, Kruhl C, Kotecha R, Wang BC

    Published 2025-02-01
    “…Wesley Furnback,1 Elizabeth Wu,1 Cloe Ying Chee Koh,2 Jorge Fernando Nino de Rivera Guzman,2 Christian Kruhl,3 Rupesh Kotecha,4 Bruce CM Wang3 1Real Chemistry, New York, NY, USA; 2Novocure, Inc, Portsmouth, NH, USA; 3Novocure GmbH, Root, Switzerland; 4Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL, USACorrespondence: Bruce CM Wang, Novocure GmbH, Neuhofstrasse 21, Baar, 6340, Switzerland, Email bcwang@novocure.comPurpose: Lung cancer remains a leading cause of cancer-related mortality. …”
    Get full text
    Article
  4. 6984
  5. 6985
  6. 6986
  7. 6987

    Integrative analysis of miRNA expression data reveals a minimal signature for tumour cells classification by Sabrina Napoletano, David Dannhauser, Paolo Antonio Netti, Filippo Causa

    Published 2025-01-01
    “…Our work paves the way for multi-cancer classification, emphasizing the transformative potential of miRNA research in oncology. Beyond advancing the understanding of tumour biology, our step-by-step guide offers a robust tool for a wide range of users to investigate precise diagnostics and promising therapeutic strategies.…”
    Get full text
    Article
  8. 6988
  9. 6989
  10. 6990
  11. 6991
  12. 6992
  13. 6993
  14. 6994
  15. 6995
  16. 6996
  17. 6997
  18. 6998
  19. 6999
  20. 7000

    Ketamine Infusion as an Adjunct to Opioid Analgesia in Pediatric Patients with High-Risk Neuroblastoma Undergoing Treatment with Dinutuximab: Adverse Effects and Safety in a Non-IC... by Streby KA, Tobias JD, McPhaden E, Downie S, Stanek J, Roth C, Patel PO

    Published 2025-01-01
    “…Keri A Streby,1,* Joseph D Tobias,2,3,* Evan McPhaden,4 Shannon Downie,4 Joseph Stanek,1 Catherine Roth,2 Priyal O Patel1,2 1Department of Pediatrics- Division of Pediatric Oncology, Nationwide Children’s Hospital and The Ohio State University College of Medicine, Columbus, OH, USA; 2Department of Anesthesiology & Pain Medicine, Nationwide Children’s Hospital, Columbus, OH, USA; 3Department of Anesthesiology & Pain Medicine, The Ohio State University College of Medicine, Columbus, OH, USA; 4Ohio University Heritage College of Osteopathic Medicine, Dublin Campus and Ohio University, Athens, OH, USA*These authors contributed equally to this workCorrespondence: Priyal O Patel, DO Department of Anesthesiology & Pain Medicine Nationwide Children’s Hospital, 700 Children’s Drive, Columbus, Ohio, 43205, USA, Tel +1-(614) 722-3728, Fax +1-(614) 722-4203, Email priyal.patel@nationwidechildrens.orgIntroduction: Anti-GD2 immunotherapy has improved outcomes for children with high-risk neuroblastoma (HRNBL). …”
    Get full text
    Article